{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:11:37Z","timestamp":1791565897064,"version":"4.3.4"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ogc.2018.10.002","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T08:13:11Z","timestamp":1548403991000},"page":"165-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Gynecologic Cancer Survivorship"],"prefix":"10.1016","volume":"46","author":[{"given":"Elizabeth","family":"Lokich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogc.2018.10.002_bib1","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology: ovarian cancer including fallopian tube cancer and primary peritoneal cancer. Version 2.2018. March 2018. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ovarian.pdf. Accessed May 5, 2018."},{"issue":"3","key":"10.1016\/j.ogc.2018.10.002_bib2","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ygyno.2005.03.006","article-title":"Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva","volume":"97","author":"Gonzalez Bosquet","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ogc.2018.10.002_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2013.05.022","article-title":"Survivorship planning in gynecologic cancer patients","volume":"130","author":"Salani","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ogc.2018.10.002_bib4","series-title":"From cancer patient to cancer survivor: lost in translation","author":"Hewitt","year":"2005"},{"issue":"6","key":"10.1016\/j.ogc.2018.10.002_bib5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajog.2011.03.008","article-title":"Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations","volume":"204","author":"Salani","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2018.10.002_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2017.03.022","article-title":"An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations","volume":"146","author":"Salani","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ogc.2018.10.002_bib7","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology: uterine neoplasms. Version 1.2018. October 2017. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/uterine.pdf. Accessed May 5, 2018."},{"issue":"3","key":"10.1016\/j.ogc.2018.10.002_bib8","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A\u00a0phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ogc.2018.10.002_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0090-8258(03)00126-4","article-title":"Survival after relapse in patients with endometrial cancer: results from a randomized trial","volume":"89","author":"Creutzberg","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ogc.2018.10.002_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/gyno.1995.1262","article-title":"Postsurgical surveillance of patients with FIGO stage I\/II endometrial adenocarcinoma","volume":"59","author":"Berchuck","year":"1995","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ogc.2018.10.002_bib11","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/ijgc-00009577-200409000-00029","article-title":"The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients","volume":"14","author":"Tjalma","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ogc.2018.10.002_bib12","unstructured":"Noone AM, Howlader N, Krapcho M, et\u00a0al. SEER cancer statistics review, 1975-2015 - SEER Statistics. 2018. Available at: https:\/\/seer.cancer.gov\/csr\/1975_2015\/. Accessed May 10, 2018."},{"issue":"1","key":"10.1016\/j.ogc.2018.10.002_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1525-1438.2007.00826.x","article-title":"Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature","volume":"17","author":"Gadducci","year":"2007","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ogc.2018.10.002_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/jnci\/95.2.113","article-title":"International collaborative ovarian neoplasm trial 1 and adjuvant chemotherapy in ovarian neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma","volume":"95","author":"Trimbos","year":"2003","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"3A","key":"10.1016\/j.ogc.2018.10.002_bib15","first-page":"1551","article-title":"Evaluation of CA125, physical and radiological findings in follow-up of ovarian cancer patients","volume":"25","author":"Fehm","year":"2005","journal-title":"Anticancer Res"},{"issue":"9747","key":"10.1016\/j.ogc.2018.10.002_bib16","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(10)61268-8","article-title":"Early versus delayed treatment of relapsed ovarian cancer (MRC OV05\/EORTC 55955): a randomised trial","volume":"376","author":"Rustin","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ogc.2018.10.002_bib17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0090-8258(90)90072-S","article-title":"Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study","volume":"38","author":"Delgado","year":"1990","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ogc.2018.10.002_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3747\/co.v17i3.514","article-title":"Follow-up for women after treatment for cervical cancer","volume":"17","author":"Elit","year":"2010","journal-title":"Curr Oncol"},{"issue":"3","key":"10.1016\/j.ogc.2018.10.002_bib19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0090-8258(88)90252-1","article-title":"Recurrent cervical carcinoma after radical hysterectomy","volume":"30","author":"Larson","year":"1988","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.ogc.2018.10.002_bib20","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.6004\/jnccn.2010.0104","article-title":"Cervical cancer","volume":"8","author":"Greer","year":"2010","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.ogc.2018.10.002_bib21","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology: cervical cancer. Version 1.2018. October 2017. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cervical.pdf. Accessed May 5, 2018."},{"issue":"Suppl 1","key":"10.1016\/j.ogc.2018.10.002_bib22","first-page":"S7","article-title":"Carcinoma of the vulva. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Beller","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ogc.2018.10.002_bib23","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology: vulvar cancer. Version I.2018. October 2017. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/vulvar.pdf. Accessed May 5, 2018."},{"key":"10.1016\/j.ogc.2018.10.002_bib24","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology: survivorship 3.2017. 2018. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/survivorship.pdf. Accessed May 5, 2018."},{"issue":"17","key":"10.1016\/j.ogc.2018.10.002_bib25","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.ogc.2018.10.002_bib26","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1200\/JCO.2010.27.9752","article-title":"Weight, physical activity, diet, and prognosis in breast and gynecologic cancers","volume":"28","author":"McTiernan","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ogc.2018.10.002_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/AOG.0b013e31820205b3","article-title":"Lifestyle challenges in endometrial cancer survivorship","volume":"117","author":"von Gruenigen","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2018.10.002_bib28","unstructured":"The American Cancer Society medical and editorial content team. ACS guidelines for nutrition and physical activity. 2017. Available at: https:\/\/www.cancer.org\/healthy\/eat-healthy-get-active\/acs-guidelines-nutrition-physical-activity-cancer-prevention\/guidelines.html. Accessed May 5, 2018."},{"issue":"17","key":"10.1016\/j.ogc.2018.10.002_bib29","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1200\/JCO.2013.53.4495","article-title":"Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation","volume":"32","author":"Bower","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ogc.2018.10.002_bib30","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology: genetic\/familial high-risk assessment: colorectal 3.2017. 2017. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_colon.pdf."},{"issue":"3","key":"10.1016\/j.ogc.2018.10.002_bib31","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ygyno.2011.11.005","article-title":"Cognitive function and quality of life in ovarian cancer","volume":"124","author":"Correa","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ogc.2018.10.002_bib32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ygyno.2011.11.034","article-title":"Patient reported late effects of gynecological cancer treatment","volume":"124","author":"Grover","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ogc.2018.10.002_bib33","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.suponc.2010.09.028","article-title":"Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancer","volume":"8","author":"Hess","year":"2010","journal-title":"J\u00a0Support Oncol"},{"issue":"3","key":"10.1016\/j.ogc.2018.10.002_bib34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejca.2009.12.008","article-title":"Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools","volume":"46","author":"Cavaletti","year":"2010","journal-title":"Eur J Cancer"},{"issue":"18","key":"10.1016\/j.ogc.2018.10.002_bib35","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"32","author":"Hershman","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.ogc.2018.10.002_bib36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/clpt.2011.115","article-title":"Chemotherapy-induced peripheral neuropathy: prevention and treatment","volume":"90","author":"Pachman","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"13","key":"10.1016\/j.ogc.2018.10.002_bib37","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial","volume":"309","author":"Smith","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ogc.2018.10.002_bib38","doi-asserted-by":"crossref","unstructured":"Carlson JW, Kauderer J, Hutson A, et\u00a0al. GOG 244; the lymphedema and gynecologic cancer (LEG) study: incidence and risk factors in newly diagnosed patients. Abstract presented at the: SGO Annual Meeting 2018; March 25, 2018; New Orleanse, LA.","DOI":"10.1016\/j.ygyno.2018.04.022"},{"issue":"1","key":"10.1016\/j.ogc.2018.10.002_bib39","first-page":"1","article-title":"The diagnosis and treatment of peripheral lymphedema: 2013 consensus document of the International Society of Lymphology","volume":"46","author":"International Society of Lymphology","year":"2013","journal-title":"Lymphology"},{"key":"10.1016\/j.ogc.2018.10.002_bib40","unstructured":"National Cancer Institute. National Cancer Institute Lymphedema (PDQ\u00ae)\u2013Health Professional Version. July 2015. National Cancer Institute Lymphedema (PDQ\u00ae)\u2013Health Professional Version. Available at: https:\/\/www.cancer.gov\/about-cancer\/treatment\/side-effects\/lymphedema\/lymphedema-hp-pdf. Accessed May 13, 2018."},{"key":"10.1016\/j.ogc.2018.10.002_bib41","unstructured":"National Lymphedema Network. Position statement of the national lymphedema network. 2011. Available at: https:\/\/www.lymphnet.org\/pdfDocs\/position.papers\/Risk.Reduction.pdf. Accessed May 13, 2018."},{"issue":"2","key":"10.1016\/j.ogc.2018.10.002_bib42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ygyno.2006.08.036","article-title":"Long-term survival from gynecologic cancer: psychosocial outcomes, supportive care needs and positive outcomes","volume":"104","author":"Hodgkinson","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ogc.2018.10.002_bib43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/pon.567","article-title":"Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study","volume":"11","author":"Wenzel","year":"2002","journal-title":"Psychooncology"},{"issue":"3","key":"10.1016\/j.ogc.2018.10.002_bib44","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11764-013-0272-z","article-title":"Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies","volume":"7","author":"Simard","year":"2013","journal-title":"J\u00a0Cancer Surviv"},{"issue":"6","key":"10.1016\/j.ogc.2018.10.002_bib45","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1017\/S1478951515000127","article-title":"A\u00a0systematic review of ovarian cancer and fear of recurrence","volume":"13","author":"Ozga","year":"2015","journal-title":"Palliat Support Care"},{"issue":"2","key":"10.1016\/j.ogc.2018.10.002_bib46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/07347332.2013.874004","article-title":"Population-level trends in posttreatment cancer survivors\u2019 concerns and associated receipt of care: results from the 2006 and 2010 LIVESTRONG surveys","volume":"32","author":"Beckjord","year":"2014","journal-title":"J\u00a0Psychosoc Oncol"},{"issue":"3","key":"10.1016\/j.ogc.2018.10.002_bib47","first-page":"901","article-title":"Does fear of cancer recurrence predict cancer survivors\u2019 health care use?","volume":"21","author":"Lebel","year":"2013","journal-title":"Support Care Cancer"},{"issue":"15","key":"10.1016\/j.ogc.2018.10.002_bib48","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1200\/JCO.2013.52.4611","article-title":"Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation","volume":"32","author":"Andersen","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.ogc.2018.10.002_bib49","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J\u00a0Gen Intern Med"},{"issue":"2","key":"10.1016\/j.ogc.2018.10.002_bib50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1258\/mi.2010.010018","article-title":"Menopause, hormone replacement and gynaecological cancers","volume":"16","author":"Hinds","year":"2010","journal-title":"Menopause Int"},{"issue":"3","key":"10.1016\/j.ogc.2018.10.002_bib51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/GME.0000000000000508","article-title":"Hormone therapy for ovarian cancer survivors: systematic review and meta-analysis","volume":"23","author":"Pergialiotis","year":"2016","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.ogc.2018.10.002_bib52","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ygyno.2015.07.109","article-title":"Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis","volume":"139","author":"Li","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"35","key":"10.1016\/j.ogc.2018.10.002_bib53","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1200\/JCO.2015.60.9719","article-title":"Adjuvant hormone therapy may improve survival in epithelial ovarian cancer: results of the AHT randomized trial","volume":"33","author":"Eeles","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.ogc.2018.10.002_bib54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.2005.02.8464","article-title":"Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study","volume":"24","author":"Barakat","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.ogc.2018.10.002_bib55","first-page":"283","article-title":"ACOG committee opinion. Hormone replacement therapy in women treated for endometrial cancer. Number 234, May 2000 (replaces number 126, August 1993)","volume":"73","year":"2001","journal-title":"Int J Gynaecol Obstet"},{"issue":"9247","key":"10.1016\/j.ogc.2018.10.002_bib56","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","article-title":"Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial","volume":"356","author":"Loprinzi","year":"2000","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ogc.2018.10.002_bib57","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ajog.2011.10.858","article-title":"Gynecologic care for breast cancer survivors: assisting in the transition to wellness","volume":"206","author":"Salani","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2018.10.002_bib58","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ygyno.2015.11.010","article-title":"Maintaining sexual health throughout gynecologic cancer survivorship: a comprehensive review and clinical guide","volume":"140","author":"Huffman","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ogc.2018.10.002_bib59","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ygyno.2011.07.035","article-title":"Survivors of endometrial cancer: who is at risk for sexual dysfunction?","volume":"123","author":"Onujiogu","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.ogc.2018.10.002_bib60","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.ejca.2011.11.014","article-title":"Five-year quality of life of endometrial cancer patients treated in the randomised post operative radiation therapy in endometrial cancer (PORTEC-2) trial and comparison with norm data","volume":"48","author":"Nout","year":"2012","journal-title":"Eur J Cancer"},{"issue":"30","key":"10.1016\/j.ogc.2018.10.002_bib61","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1200\/JCO.2004.00.3996","article-title":"Quality of life and sexual functioning in cervical cancer survivors","volume":"23","author":"Frumovitz","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ogc.2018.10.002_bib62","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1634\/theoncologist.2013-0302","article-title":"Sexual health as a survivorship issue for female cancer survivors","volume":"19","author":"Dizon","year":"2014","journal-title":"Oncologist"},{"issue":"18","key":"10.1016\/j.ogc.2018.10.002_bib63","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1002\/cncr.26739","article-title":"Psychometric validation of the female sexual function index (FSFI) in cancer survivors","volume":"118","author":"Baser","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ogc.2018.10.002_bib64","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1477-7525-11-40","article-title":"Construct validity of the PROMIS\u00ae sexual function and satisfaction measures in patients with cancer","volume":"11","author":"Flynn","year":"2013","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"10.1016\/j.ogc.2018.10.002_bib65","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.fertnstert.2013.08.018","article-title":"Sexual dysfunction in women with cancer","volume":"100","author":"Falk","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ogc.2018.10.002_bib66","series-title":"Diagnostic and statistical manual of mental disorders: DSM-5","author":"A.P. Association","year":"2013"},{"issue":"1","key":"10.1016\/j.ogc.2018.10.002_bib67","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/IGC.0b013e3181bf7d3f","article-title":"Cancer-related infertility in survivorship","volume":"20","author":"Carter","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ogc.2018.10.002_bib68","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.78.1914","article-title":"Fertility preservation in patients with cancer: ASCO clinical practice guideline update","author":"Oktay","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"17","key":"10.1016\/j.ogc.2018.10.002_bib69","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMp1709585","article-title":"Mandating coverage for fertility preservation - a step in the right direction","volume":"377","author":"Cardozo","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.ogc.2018.10.002_bib70","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJMra1614676","article-title":"Fertility preservation in women","volume":"377","author":"Donnez","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ogc.2018.10.002_bib71","unstructured":"The Americans with Disabilities Act of 1990. Available at: https:\/\/www.eeoc.gov\/eeoc\/history\/35th\/thelaw\/ada.html. Accessed May 13, 2018."},{"issue":"3","key":"10.1016\/j.ogc.2018.10.002_bib72","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ygyno.2013.02.037","article-title":"Do survivorship care plans impact patients\u2019 evaluations of care? a randomized evaluation with gynecologic oncology patients","volume":"129","author":"Brothers","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ogc.2018.10.002_bib73","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1200\/JCO.2003.03.060","article-title":"Quality of non-breast cancer health maintenance among elderly breast cancer survivors","volume":"21","author":"Earle","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.ogc.2018.10.002_bib74","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/sj.bjc.6605609","article-title":"Cancer screening and preventative care among long-term cancer survivors in the United Kingdom","volume":"102","author":"Khan","year":"2010","journal-title":"Br J Cancer"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854518301001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854518301001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:18:32Z","timestamp":1760177912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854518301001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0889854518301001"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2018.10.002","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gynecologic Cancer Survivorship","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2018.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}